Shopping Cart
- Remove All
- Your shopping cart is currently empty
FGFR-IN-7 (compound 17) is an orally active, potent FGFR modulator that penetrates the blood-brain barrier, exhibits neuroprotective properties, enhances brain exposure, and decreases the likelihood of phospholidosis, proving valuable for research on neurodegenerative diseases [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | FGFR-IN-7 (compound 17) is an orally active, potent FGFR modulator that penetrates the blood-brain barrier, exhibits neuroprotective properties, enhances brain exposure, and decreases the likelihood of phospholidosis, proving valuable for research on neurodegenerative diseases [1]. |
In vivo | FGFR-IN-7 (compound 17), administered orally at a dosage of 1 mg/kg once daily for a duration of 10 days, significantly improves the recovery of coordinated movement in rats within an acute stroke model in vivo [1]. |
Molecular Weight | 374.81 |
Formula | C16H21ClF2N4O2 |
Cas No. | 2488764-17-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.